Summit Therapeutics Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $33.89 on 09/16/24 and a low of $1.64 for the same time frame on 11/09/23.
52-week price history of SMMT Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Summit Therapeutics Inc’s current trading price is -38.37% away from its 52-week high, while its distance from the 52-week low is 1173.48%. The stock’s price range during the 52-week period has remained between $1.64 and $33.89. In the Healthcare sector, the company’s shares saw a trading volume of around 5.65 million for the day, which was evidently higher than the average daily volume of 4.73 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Summit Therapeutics Inc (SMMT) has experienced a quarterly rise of 167.76% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 15.13B and boasts a workforce of 105 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.13, with a change in price of +16.42. Similarly, Summit Therapeutics Inc recorded 5,107,430 in trading volume during the last 100 days, posting a change of +367.23%.
Examining SMMT’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for SMMT stands at 0.56. Similarly, the long-term debt-to-equity ratio is also 0.03.
SMMT Stock Stochastic Average
As of today, Summit Therapeutics Inc’s raw stochastic average for the last 50 days stands at 48.35%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 41.23%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 46.78% and 49.45%, respectively.
SMMT Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price increase of 700.19%. However, over the past six months, we’ve seen a weaker performance of 404.47%. The price of SMMT fallen by 59.18% over the last 30 days. And in the last five days, it has fallen by -14.37%.
